These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3778785)

  • 1. Development of a regenerated cellulose non-complement activating membrane for hemodialysis.
    Akizawa T; Kitaoka T; Koshikawa S; Watanabe T; Imamura K; Tsurumi T; Suma Y; Eiga S
    ASAIO Trans; 1986; 32(1):76-80. PubMed ID: 3778785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical study on different cellulosic dialysis membranes.
    Falkenhagen D; Bosch T; Brown GS; Schmidt B; Holtz M; Baurmeister U; Gurland H; Klinkmann H
    Nephrol Dial Transplant; 1987; 2(6):537-45. PubMed ID: 3126455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukopenia, hypoxia, and complement function with different hemodialysis membranes.
    Jacob AI; Gavellas G; Zarco R; Perez G; Bourgoignie JJ
    Kidney Int; 1980 Oct; 18(4):505-9. PubMed ID: 7230613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes.
    Stannat S; Bahlmann J; Kiessling D; Koch KM; Deicher H; Peter HH
    Contrib Nephrol; 1985; 46():102-8. PubMed ID: 3874042
    [No Abstract]   [Full Text] [Related]  

  • 7. Biocompatibility of membranes used in the treatment of renal failure.
    Hoenich NA; Woffindin C; Mathews JN; Vienken J
    Biomaterials; 1995 May; 16(8):587-92. PubMed ID: 7548608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetically modified cellulose (SMC): a cellulosic hemodialysis membrane with minimized complement activation.
    Bowry SK; Rintelen TH
    ASAIO J; 1998; 44(5):M579-83. PubMed ID: 9804499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of the Limulus amebocyte lysate-reactive substances flushed from cellulose hemodialysis membranes].
    Strokov AG; Baeva LB; Levitskiĭ ER; Tiagny-Riadno LI
    Urol Nefrol (Mosk); 1993; (3):41-4. PubMed ID: 7941162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modification of cellulose that facilitates the control of complement activation.
    Johnson RJ; Lelah MD; Sutliff TM; Boggs DR
    Blood Purif; 1990; 8(6):318-28. PubMed ID: 2151203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellulose carbamates and derivatives as hemocompatible membrane materials for hemodialysis.
    Diamantoglou M; Platz J; Vienken J
    Artif Organs; 1999 Jan; 23(1):15-22. PubMed ID: 9950174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane].
    Pak K; Kobira S; Tomoyoshi T; Nishimura N
    Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
    Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
    Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polycarbonate hemodialysis membrane: neutrophil, platelet, complement and chemiluminescence kinetics during first and second use.
    Heierli C; Markert M; Frei J; Lambert PH; Wauters JP
    Blood Purif; 1986; 4(1-3):82-7. PubMed ID: 3730165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellulose-based haemodialysis membranes: biocompatibility and functional performance compared.
    Woffindin C; Hoenich NA; Matthews JN
    Nephrol Dial Transplant; 1992; 7(4):340-5. PubMed ID: 1317525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
    Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E-bonded cellulose membrane and hemodialysis bioincompatibility: absence of an acute benefit on expression of leukocyte surface molecules.
    Dhondt A; Vanholder R; Glorieux G; Waterloos MA; De Smet R; Lesaffer G; Lameire N
    Am J Kidney Dis; 2000 Dec; 36(6):1140-6. PubMed ID: 11096038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation during hemodialysis.
    Agostoni A; Gardinali M
    J Biomater Appl; 1989 Oct; 4(2):102-22. PubMed ID: 2677307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellulose-ester as membrane materials for hemodialysis.
    Diamantoglou M; Lemke HD; Vienken J
    Int J Artif Organs; 1994 Jul; 17(7):385-91. PubMed ID: 7806425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.